Researchers appear to have found a solution for breast cancer patients who do not respond well enough to the common treatment tamoxifen, according to results from a German study.
Researchers have converted a blood type A kidney to a blood type O kidney and successfully transplanted it, they reported in Nature Biomedical Engineering, an advance that could reduce wait times for new organs and save lives.
The age of the father plays a role in pregnancy outcomes, with harmful genetic changes in sperm being substantially more common in older men, new research shows.
Genetic factors contribute more to depression risk in females than in males, according to a large Australian study that may help further understanding of why women are more likely to suffer from the condition.
An experimental cannabis-derived medication was safer and more effective than placebo and opioids for treating chronic lower back pain in two late-stage trials, researchers said.
Low-dose radiotherapy is a safe, effective treatment for mild-to-moderate osteoarthritis, three research teams reported in San Francisco at the annual meeting of the American Society for Radiation Oncology (ASTRO).
Cross-sectional, observational study reveals that diagnostic delays and misdiagnoses remain common across CIDP variants
The latest from FLAURA2 and NorthStar presented at ESMO 2025 offers guidance on the use of osimertinib in EGFR-mutated NSCLC.
Alectinib treatment results in large survival gains versus crizotinib in advanced ALK-positive NSCLC, report the ALEX investigators at ESMO 2025.
GDFATHER-NEO: Adding the GDF-15 inhibitor visugromab to nivolumab improves outcomes for patients with MIBC unfit for neoadjuvant chemotherapy.
Final survival analysis of the BladderPath trial supports use of MRI-based staging for patients with suspected muscle-invasive bladder cancer.
HARMONi-6 data show ivonescimab plus chemotherapy improves PFS in advanced squamous non–small-cell lung cancer, as seen at ESMO 2025.
Combining disitamab vedotin with toripalimab is superior to platinum-based chemotherapy in HER2-positive advanced urothelial carcinoma.
Results of OptiTROP-Lung04 show increased survival with sacituzumab tirumotecan in EGFR-mutated non–small-cell lung cancer (NSCLC) at ESMO 2025.
Cancer patients who received mRNA-based COVID vaccines within 100 days of starting treatment with widely used immunotherapies were twice as likely to be alive three years after beginning treatment, researchers reported.
A newer class of cancer drugs can delay disease progression or extend survival for breast cancer patients, multiple teams of researchers reported at a major European oncology meeting.
Serious cases of a disorder of the large intestine are surging among Americans younger than 50, researchers say.
Tiny viruses that only infect and kill bacteria can help treat deadly antibiotic-resistant bloodstream infections with Staphylococcus aureus, results from a mid-stage trial suggest.
